Astrazeneca Share News (AZN)

Daiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatment

(Alliance News) - Daiichi Sankyo Co Ltd on Monday said the first patient has been dosed in its Tropion-Lung07 phase 3 trial, which is evaluating a combination of treatments for patients with metastatic non-small cell lung cancer.

IN BRIEF: AstraZeneca loses emergency use authorisation for Evusheld

AstraZeneca PLC - Cambridge, England-based pharmaceutical firm - Reports that the US Food & Drug Administration withdrew its authorisation for the emergency use of Evusheld, a medicine used to prevent Covid-19 in adults and adolescents, for the emergency use for pre-exposure prophylaxis of Covid-19 in the US. Says that the FDA will make a determination about reinstating authorisation of Evusheld if the national prevalence of resistant variants decreases to 90%. Explains that the withdrawal is due the sustained high frequency of circulating SARS-CoV-2 variants that Evusheld does not retain in vitro neutralisation against.

TOP NEWS: AstraZeneca's Enhertu approved in EU for breast cancer form

(Alliance News) - AstraZeneca PLC on Thursday said its cancer drug Enhertu, which it develops with Daiichi Sankyo Co Ltd, has been approved in the EU for the treatment of metastatic breast cancer.

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

FTSE 100 dips after weak economic data fans recession fears

UK PMI falls at fastest rate in 2 years

*

JPMorgan sees potential for $1 trillion equity selling

STOXX 600 down 0.34%

*

Eurozone: "Sometimes you just need a bit of luck"

STOXX 600 down 0.4%

*

LONDON MARKET OPEN: FTSE 100 lags as other indices make headway

(Correcting December borrowing figure to billion.)

STOXX dips on healthcare drag

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at

LONDON MARKET OPEN: FTSE 100 lags as other indices make headway

(Alliance News) - Stock prices in London opened mixed on Tuesday, with the FTSE 100 underperforming, as a more positive mood prevailed elsewhere.

LONDON BROKER RATINGS: Jefferies cuts Berkeley; HSBC cuts St James's

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Wall Street rally keeps Nasdaq Composite above key level

Major U.S. stock indexes end green: Nasdaq up ~2.7%

*

S&P 500 earnings estimate weakens in the latest week

Major U.S. stock indexes green; Nasdaq up ~1.7%

*

Big Tech to squeeze more revenue per employee with layoffs

Major U.S. stock indexes green; Nasdaq up ~1.5%

*

Biotech off to strong start but rocky recovery seen

Major U.S. stock indexes green; Nasdaq up ~1.4%

*